eFFECTOR Therapeutics Inc. (NASDAQ: EFTR)
$0.19
+0.1090 ( +135.40% ) 1.6M
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Market Data
Open
$0.19
Previous close
$0.08
Volume
1.6M
Market cap
$0.61M
Day range
$0.13 - $0.26
52 week range
$0.03 - $20.61
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Nov 16, 2023 |
| 4 | Insider transactions | 1 | Nov 16, 2023 |
| 10-q | Quarterly Reports | 80 | Nov 13, 2023 |
| 8-k | 8K-related | 15 | Nov 13, 2023 |
| 3 | Insider transactions | 2 | Sep 11, 2023 |
| 8-k | 8K-related | 13 | Sep 11, 2023 |
| 4 | Insider transactions | 1 | Sep 11, 2023 |
| 4 | Insider transactions | 1 | Aug 14, 2023 |
| 8-k | 8K-related | 15 | Aug 08, 2023 |
| 10-q | Quarterly Reports | 81 | Aug 08, 2023 |